Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery

논문상세정보
    • 저자 정승현 장지훈 조혜영 이용복
    • 제어번호 105918017
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 41 No. 8 [ 2018 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 797-814 ( 18쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)

' Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery' 의 참고문헌

  • Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin
    Jenning V [2000]
  • Use of nanoparticle concentration as a tool to understand the structural properties of colloids
  • Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants
    Kitaoka M [2015]
  • The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
    Fassas A [2005]
  • The role of tumor lymphangiogenesis in metastatic spread
    Stacker SA [2002]
  • The lymph node microenvironment and its role in the progression of metastatic cancer
    Pereira ER [2015]
  • The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review
    Bahari LAS [2016]
  • Techniques for the preparation of solid lipid nano and microparticles; Application of nanotechnology in drug delivery
    Battaglia L [2014]
  • Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy
    Dierling AM [2005]
  • Targeting colloidal particulates to thoracic lymph nodes
    Liu J [2006]
  • Targeted drug delivery
    Mills JK [1999]
  • Tamoxifen citrate loaded solid lipid nanoparticles (<TEX>$SLN^{TM}$</TEX>): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation
    Reddy LH [2006]
  • Synthesis and characterization of lipid-polymer hybrid nanoparticles for combinatorial drug delivery
  • Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
    Moghimi S [1994]
  • Supersaturated polymeric micelles for oral cyclosporine A delivery: the role of Soluplus-sodium dodecyl sulfate complex
    Xia D [2016]
  • Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography
    Moghimi S [1999]
  • Study of formulation and stability of co-surfactant free water-in-olive oil nano-and submicron emulsions with food grade non-ionic surfactants
  • Structural biochemistry/lipids/micelles. Wikibooks, The Free Textbook Project
  • State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications
    Mirtallo JM [2010]
  • Stability of lipid emulsions for drug delivery
  • Stability evaluation of celecoxib nanoemulsion containing Tween 80
    Shakeel F [2008]
  • Solid lipid nanoparticles: production, characterization and applications
    Mehnert W [2001]
  • Solid lipid nanoparticles: a review
    Ekambaram P [2012]
  • Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases
    Lu B [2006]
  • Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies
    Soma D [2017]
  • Solid lipid nanoparticles for parenteral drug delivery
    Wissing SA [2004]
  • Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application
    Naseri N [2015]
  • Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers
    Shidhaye S [2008]
  • Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art
    Muller RH [2000]
  • Sirolimus (rapamycin, <TEX>$Rapamune^{(R)}$</TEX>) and combination therapy with cyclosporin A in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations
    Carlson RP [1998]
  • Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymerlipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer
    Wong HL [2006]
  • Silica nanoparticle as a lymph node targeting platform for vaccine delivery
    An M [2017]
  • Self-emulsifying drug delivery system for enhancing bioavailability and lymphatic delivery of tacrolimus
    Cho HY [2015]
  • Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform
    Zhang L [2008]
  • Role of liposome in novel drug delivery system
    Dwivedi C [2014]
  • Recent developments in lipidbased pharmaceutical nanocarriers
    Musacchio T [2011]
  • Recent advances in lymphatic targeted drug delivery system for tumor metastasis
    Zhang XY [2014]
  • Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery
  • Progress of lymph-targeted contrast agents and their application in diagnosis of tumor lymphatic metastasis
    Zhang Y [2017]
  • Primary and secondary lymphatic valve development: molecular, functional and mechanical insights
    Bazigou E [2014]
  • Preparation of tacrolimus loaded micelles based on poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone)
    Wang Y [2011]
  • Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique
    Trotta M [2003]
  • Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake
    Hawley AE [1997]
  • Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery
    Shin SB [2010]
  • Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery
    Kim CK [2001]
  • Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  • Powder flow; Aulton's pharmaceutics: the design and manufacture of medicines, 4th edn
    Aulton ME [2013]
  • Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids
    Wang J [2005]
  • Polymeric micelles as a drug delivery system enhance cytotoxicity of vinorelbine through more intercellular accumulation
    Lu X [2010]
  • Physical states of surface and core lipids in lipid emulsions and apolipoprotein binding to the emulsion surface
    Saito H [1996]
  • Physical adsorption of bilayer membranes on silica
    Rapuano R [1997]
  • Phase inversion temperature (PIT) emulsification process
    Friberg SE [2011]
  • Pharmacokinetics of lopromide liposomes in rabbits
  • Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route
    Uno T [1999]
  • Pharmaceutical dosage forms: disperse systems
    Banker G [2002]
  • Pegylated liposomal doxorubicin as adjuvant therapy for stage I-III operable breast cancer
    Lu YC [2016]
  • Particles as surfactants-similarities and differences
    Binks BP [2002]
  • PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery
    Chan JM [2009]
  • PEGylated nanoparticles for biological and pharmaceutical applications
    Otsuka H [2003]
  • PEG-PE/clay composite carriers for doxorubicin: effect of composite structure on release, cell interaction and cytotoxicity
    Kohay H [2017]
  • Optimization strategies in lymph node targeting of interstitially injected immunoglobulin G-bearing liposomes;Liposome technology: interaction of liposomes with the biological milieu
    Moghimi S [2006]
  • Novel modified nanosystem based lymphatic targeting
    Saraf S [2011]
  • Novel formulation of cytarabine and daunorubicin: a new hope in AML treatment
    Raut LS [2015]
  • New developments in liposomal drug delivery
    Pattni BS [2015]
  • Nanostructured lipid carriers: a novel generation of solid lipid drug carriers
    Radtke M [2005]
  • Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: design and in vivo study
    Shah NV [2016]
  • Nanoparticles: properties, applications and toxicities
    Khan I [2017]
  • Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels
    Asai T [2012]
  • Nanoparticle engineering for the lymphatic system and lymph node targeting;Polymer-based nanostructures: medical applications
    Moghimi S [2010]
  • Nanoemulsion: concepts, development and applications in drug delivery
    Singh Y [2017]
  • Nanoemulsion: an advanced mode of drug delivery system. 3
    Jaiswal M [2015]
  • Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
  • Nanoemulsion formulations for tumortargeted delivery;Nanotechnology for cancer therapy
    Tiwari SB [2006]
  • Nanocrystal technology, drug delivery and clinical applications
  • Nano-sized drug delivery systems for lymphatic delivery
    Cho HY [2014]
  • Nano-emulsions
    Solans C [2005]
  • Nano-emulsion production by sonication and microfluidization: a comparison
  • Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation
    Bouchemal K [2004]
  • Molecular-thermodynamic approach to predict micellization, phase behavior and phase separation of micellar solutions. I. Application to nonionic surfactants
    Puvvada S [1990]
  • Miniemulsion polymerization
    Asua JM [2002]
  • Micelle shape and size
    Tanford C [1972]
  • Methods for preparation of drug-loaded polymeric nanoparticles
    Reis CP [2006]
  • Mechanistic aspects of the adsorption of phospholipids onto lauric acid stabilized magnetite nanocolloids
    De Cuyper M [1991]
  • Lymphatic uptake of lipid nanoparticles following endotracheal administration
    Videira MA [2006]
  • Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes
    Oussoren C [1998]
  • Lymphatic targeting of zidovudine using surface-engineered liposomes
    Kaur CD [2008]
  • Lymphatic system: a prospective area for advanced targeting of particulate drug carriers
    Singh I [2014]
  • Lymphatic endothelium in health and disease
    Jurisic G [2009]
  • Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
    Cai S [2011]
  • Lymph drainage from the mammary glands in mice: a magnetic resonance lymphographic study with gadofluorine M
    Sheng F [2011]
  • Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan
    Sheng Y [2009]
  • Liposome: classification, preparation, and applications
  • Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention
  • Liposome-encapsulated actinomycin D: potential in cancer chemotherapy
    Rahman YE [1974]
  • Liposomal formulations of cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics
    Fahr A [2001]
  • Liposomal doxorubicin in the treatment of breast cancer patients: a review
    Lao J [2013]
  • Liposomal cisplatin: a new cisplatin formulation
  • Lipophilic prodrugs designed for intestinal lymphatic transport
    Charman WN [1996]
  • Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
    Porter CJ [2007]
  • Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update
  • Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)
    Fang JY [2008]
  • Lecithin-based nanoemulsions
    Klang V [2011]
  • Interactions between bilayer membranes and latex
  • Injectable lipid emulsions-advancements, opportunities and challenges
  • Influence of liposomal size, lipid composition and lipid dose
    Oussoren C [1997]
  • Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations
    Vyas TK [2008]
  • Globule-size distribution in injectable 20% lipid emulsions: compliance with USP requirements
    Driscoll DF [2007]
  • Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography
  • Functionalized lipid-polymer hybrid nanoparticles mediated codelivery of methotrexate and aceclofenac: a synergistic effect in breast cancer with improved pharmacokinetics attributes
    Garg NK [2017]
  • Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer
    Sun SB [2015]
  • Formation and stability of nano-emulsions
    Tadros T [2004]
  • Factors affecting the clearance and biodistribution of polymeric nanoparticles
    Alexis F [2008]
  • FK506-loaded solid lipid nanoparticles: preparation, characterization and in vitro transdermal drug delivery
    Wang R [2012]
  • Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions
    Wang X [2008]
  • Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patientderived, advanced prostate cancer tissue xenograft model
    Qu S [2014]
  • Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability
  • Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy
    Youm I [2011]
  • Emission and absorption properties of indocyanine green in Intralipid solution
    Yuan B [2004]
  • Effect of particle size on the lymphatic distribution of 111Indiumaminopolystyrene through intrapleural administration
    Liu J [2008]
  • Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery
    Paliwal R [2009]
  • Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent
    Mounzer R [2007]
  • Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
    Cavalli R [2003]
  • Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies
    Xie Y [2009]
  • Drug delivery to the lymphatic system
    Porter C [1997]
  • Drug delivery systems, CNS protection, and the blood brain barrier
    Upadhyay RK [2014]
  • Drug delivery and nanoparticles: applications and hazards
    De Jong WH [2008]
  • Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH
    Kim D [2008]
  • Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes
    Niu C [2013]
  • Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience
    Crown J [2004]
  • Diffusion of univalent ions across the lamellae of swollen phospholipids
    Bangham AD [1965]
  • Development, characterization and evaluation of doxorubicin nanostructured lipid carriers for prostate cancer
    Zhang HW [2017]
  • Development of novel polymer-lipid hybrid nanoparticles of tamoxifen: in vitro and in vivo evaluation
    Varthya M [2016]
  • Development of clotrimazole multiple W/O/W emulsions as vehicles for drug delivery: effects of additives on emulsion stability
    Suner J [2017]
  • Detergents as tools in membrane biochemistry
    Garavito RM [2001]
  • Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability
    Han J [2004]
  • Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence
    Ames P [2015]
  • Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform
    Mandal B [2013]
  • Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer
    Li C [2017]
  • Conservative treatment using a methotrexate-lipiodol emulsion containing non-ionic contrast medium for a cervical ectopic pregnancy
    Nomiyama M [1997]
  • Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro
    Cai H-K [2012]
  • Chitosan-coated liposomes: characterization and interaction with leuprolide
    Guo J [2003]
  • Body distribution of camptothecin solid lipid nanoparticles after oral administration
    Yang S [1999]
  • Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery
    Rao DA [2010]
  • Barriers to drug delivery in solid tumors
    Jain RK [1994]
  • Application of liposomes in treatment of rheumatoid arthritis: quo vadis
    Kapoor B [2014]
  • Application of liposomes in medicine and drug delivery
    Daraee H [2016]
  • Anatomy and physiology of the lymphatics;Lymphatic transport of drugs
  • An improved method to prepare an injectable microemulsion of the galanin-receptor 3 selective antagonist, SNAP 37889, using <TEX>$Kolliphor^{(R)}$</TEX> HS 15
    Scheller KJ [2014]
  • Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization
    Nasr M [2012]
  • Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
    Khan AA [2013]
  • Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues
    Moghimi S [1996]
  • A tumorhoming peptide with a targeting specificity related to lymphatic vessels
    Laakkonen P [2002]
  • A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy
    Zhu Q [2014]
  • A new lipidbased nano formulation of vinorelbine
    Bahadori F [2014]
  • A model for fluid drainage by the lymphatic system
    Heppell C [2013]
  • A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation
    Karajgi JS [1994]
  • A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration
    El Mir S [2001]